Mechanism of Artificial Heart / by Takashi Yamane
By: Yamane, Takashi
Contributor(s): SpringerLink (Online service)
Material type:
E-bookPublisher: Tokyo : Springer Japan, 2016Edition: 1st ed.Description: 1 recurso en línea (X, 77 p.) : 59 ilustraciones, 22 ilustraciones en color.ISBN: 9784431558316.Subject: Corazón artificial
| Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RD598.35 .A78 Y36 2016 EB (Browse shelf(Opens below)) | .i11600251 | Acceso electrónico | eBOOK .i11600251 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| RD598.35.A77 E266 2014 EB ECMO-Extracorporeal Life Support in Adults | RD598.35.A78 2006 EB Artificial Organs | RD598.35.A78 2020 EB Artificial Hearts : Technology and Therapy Management | RD598.35 .A78 Y36 2016 EB Mechanism of Artificial Heart | RD598.35 .C35 2019 EB Percutaneous Coronary Interventions for Chronic Total Occlusion : A Guide to Success | RD598.35 .C35 2021 EB Cardiac Catheterization for Congenital Heart Disease : From Fetal Life to Adulthood | RD598.35 .C35 2021 EB Non-Pushing PCI Techniques |
Introduction -- What kinds of artificial heart are available? -- How do we select pump types? -- Selection of bearing types: Key to durability -- Motor, battery, and magnetic suspension -- Flow visualization and computational fluid dynamic analysis -- How do we select materials? -- Enhancement of hemocompatibility -- System evaluation -- Remarks and future aspects
This book first describes medical devices in relation to regenerative medicine before turning to a more specific topic: artificial heart technologies. Not only the pump mechanisms but also the bearing, motor mechanisms, and materials are described, including expert information. Design methods are described to enhance hemocompatibility: main concerns are reduction of blood cell damage and protein break, as well as prevention of blood clotting. Regulatory science from R&D to clinical trials is also discussed to verify the safety and efficacy of the devices
There are no comments on this title.